Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Structural characterization of 1-deoxy-D-xylulose 5-phosphate Reductoisomerase from Vibrio vulnificus.

Ussin NK, Bagnell AM, Offermann LR, Abdulsalam R, Perdue ML, Magee P, Chruszcz M.

Biochim Biophys Acta Proteins Proteom. 2018 Dec;1866(12):1209-1215. doi: 10.1016/j.bbapap.2018.09.008. Epub 2018 Sep 29.

PMID:
30278288
2.

Structural, Functional, and Immunological Characterization of Profilin Panallergens Amb a 8, Art v 4, and Bet v 2.

Offermann LR, Schlachter CR, Perdue ML, Majorek KA, He JZ, Booth WT, Garrett J, Kowal K, Chruszcz M.

J Biol Chem. 2016 Jul 22;291(30):15447-59. doi: 10.1074/jbc.M116.733659. Epub 2016 May 26.

3.

Structural and Functional Characterization of the Hazelnut Allergen Cor a 8.

Offermann LR, Bublin M, Perdue ML, Pfeifer S, Dubiela P, Borowski T, Chruszcz M, Hoffmann-Sommergruber K.

J Agric Food Chem. 2015 Oct 21;63(41):9150-8. doi: 10.1021/acs.jafc.5b03534. Epub 2015 Oct 7.

4.

Elusive Structural, Functional, and Immunological Features of Act d 5, the Green Kiwifruit Kiwellin.

Offermann LR, Giangrieco I, Perdue ML, Zuzzi S, Santoro M, Tamburrini M, Cosgrove DJ, Mari A, Ciardiello MA, Chruszcz M.

J Agric Food Chem. 2015 Jul 29;63(29):6567-76. doi: 10.1021/acs.jafc.5b02159. Epub 2015 Jul 21.

PMID:
26146952
5.

Permeability enhancers dramatically increase zanamivir absolute bioavailability in rats: implications for an orally bioavailable influenza treatment.

Holmes EH, Devalapally H, Li L, Perdue ML, Ostrander GK.

PLoS One. 2013 Apr 17;8(4):e61853. doi: 10.1371/journal.pone.0061853. Print 2013.

6.

The WHO research agenda for influenza: two years later.

Perdue ML, Nguyen T.

Bull World Health Organ. 2012 Apr 1;90(4):246. doi: 10.2471/BLT.11.090175. No abstract available.

7.

The future of cell culture-based influenza vaccine production.

Perdue ML, Arnold F, Li S, Donabedian A, Cioce V, Warf T, Huebner R.

Expert Rev Vaccines. 2011 Aug;10(8):1183-94. doi: 10.1586/erv.11.82. Review.

PMID:
21854311
8.

United States of America Department of Health and Human Services support for advancing influenza vaccine manufacturing in the developing world.

Perdue ML, Bright RA.

Vaccine. 2011 Jul 1;29 Suppl 1:A48-50. doi: 10.1016/j.vaccine.2011.02.080. Review.

9.

Virulence factor activity relationships for hepatitis E and Cryptosporidium.

Fayer R, Orlandi P, Perdue ML.

J Water Health. 2009;7 Suppl 1:S55-63. doi: 10.2166/wh.2009.044.

PMID:
19717931
10.
11.

Movements of birds and avian influenza from Asia into Alaska.

Winker K, McCracken KG, Gibson DD, Pruett CL, Meier R, Huettmann F, Wege M, Kulikova IV, Zhuravlev YN, Perdue ML, Spackman E, Suarez DL, Swayne DE.

Emerg Infect Dis. 2007 Apr;13(4):547-52.

12.

Impact of microbial diversity on rapid detection of enterohemorrhagic Escherichia coli in surface waters.

Shelton DR, Karns JS, Higgins JA, Van Kessel JA, Perdue ML, Belt KT, Russell-Anelli J, Debroy C.

FEMS Microbiol Lett. 2006 Aug;261(1):95-101.

13.

Subtyping Listeria monocytogenes from bulk tank milk using automated repetitive element-based PCR.

Van Kessel JS, Karns JS, Gorski L, Perdue ML.

J Food Prot. 2005 Dec;68(12):2707-12.

PMID:
16355847
14.

Public health risk from avian influenza viruses.

Perdue ML, Swayne DE.

Avian Dis. 2005 Sep;49(3):317-27. Review.

PMID:
16252482
15.

Prevalence of Salmonella enterica in bulk tank milk from US dairies as determined by polymerase chain reaction.

Karns JS, Van Kessel JS, McCluskey BJ, Perdue ML.

J Dairy Sci. 2005 Oct;88(10):3475-9.

16.

Analysis of Bacillus anthracis spores in milk using mass spectrometry.

Whiteaker J, Karns J, Fenselau C, Perdue ML.

Foodborne Pathog Dis. 2004 Fall;1(3):185-94.

PMID:
15992279
17.

Hepatitis E viruses in humans and animals.

Goens SD, Perdue ML.

Anim Health Res Rev. 2004 Dec;5(2):145-56. Review.

PMID:
15984321
18.
19.

Prevalence of Salmonellae, Listeria monocytogenes, and fecal coliforms in bulk tank milk on US dairies.

Van Kessel JS, Karns JS, Gorski L, McCluskey BJ, Perdue ML.

J Dairy Sci. 2004 Sep;87(9):2822-30.

20.

Detection and fate of Bacillus anthracis (Sterne) vegetative cells and spores added to bulk tank milk.

Perdue ML, Karns J, Higgins J, Van Kessel JA.

J Food Prot. 2003 Dec;66(12):2349-54.

PMID:
14672236
21.

Development of real-time RT-PCR for the detection of avian influenza virus.

Spackman E, Senne DA, Bulaga LL, Myers TJ, Perdue ML, Garber LP, Lohman K, Daum LT, Suarez DL.

Avian Dis. 2003;47(3 Suppl):1079-82. Erratum in: Avian Dis. 2005 Jun;49(2):313.

PMID:
14575115
22.

Molecular diagnostics in an insecure world.

Perdue ML.

Avian Dis. 2003;47(3 Suppl):1063-8.

PMID:
14575112
23.

Using a portable real-time PCR assay to detect Salmonella in raw milk.

Van Kessel JS, Karns JS, Perdue ML.

J Food Prot. 2003 Oct;66(10):1762-7.

PMID:
14572210
24.

A field investigation of Bacillus anthracis contamination of U.S. Department of Agriculture and other Washington, D.C., buildings during the anthrax attack of October 2001.

Higgins JA, Cooper M, Schroeder-Tucker L, Black S, Miller D, Karns JS, Manthey E, Breeze R, Perdue ML.

Appl Environ Microbiol. 2003 Jan;69(1):593-9.

25.
26.

Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes.

Spackman E, Senne DA, Myers TJ, Bulaga LL, Garber LP, Perdue ML, Lohman K, Daum LT, Suarez DL.

J Clin Microbiol. 2002 Sep;40(9):3256-60.

27.

Efficacy of vaccines in chickens against highly pathogenic Hong Kong H5N1 avian influenza.

Swayne DE, Beck JR, Perdue ML, Beard CW.

Avian Dis. 2001 Apr-Jun;45(2):355-65.

PMID:
11417815
28.

Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes.

Basler CF, Reid AH, Dybing JK, Janczewski TA, Fanning TG, Zheng H, Salvatore M, Perdue ML, Swayne DE, García-Sastre A, Palese P, Taubenberger JK.

Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2746-51.

29.

Influenza virus (A/HK/156/97) hemagglutinin expressed by an alphavirus replicon system protects chickens against lethal infection with Hong Kong-origin H5N1 viruses.

Schultz-Cherry S, Dybing JK, Davis NL, Williamson C, Suarez DL, Johnston R, Perdue ML.

Virology. 2000 Dec 5;278(1):55-9.

31.

Vaccines protect chickens against H5 highly pathogenic avian influenza in the face of genetic changes in field viruses over multiple years.

Swayne DE, Perdue ML, Beck JR, Garcia M, Suarez DL.

Vet Microbiol. 2000 May 22;74(1-2):165-72.

PMID:
10799788
32.

Structural features of the avian influenza virus hemagglutinin that influence virulence.

Perdue ML, Suarez DL.

Vet Microbiol. 2000 May 22;74(1-2):77-86.

PMID:
10799780
33.
34.

Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes.

Crawford J, Wilkinson B, Vosnesensky A, Smith G, Garcia M, Stone H, Perdue ML.

Vaccine. 1999 May 4;17(18):2265-74.

PMID:
10403594
35.

Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses.

Li S, Liu C, Klimov A, Subbarao K, Perdue ML, Mo D, Ji Y, Woods L, Hietala S, Bryant M.

J Infect Dis. 1999 May;179(5):1132-8.

PMID:
10191214
36.

Molecular characterization of the hemagglutinin gene and oral immunization with a waterfowl-origin avian influenza virus.

Crawford JM, Garcia M, Stone H, Swayne D, Slemons R, Perdue ML.

Avian Dis. 1998 Jul-Sep;42(3):486-96.

PMID:
9777149
37.

Multiple alignment comparison of the non-structural genes of influenza A viruses.

Suarez DL, Perdue ML.

Virus Res. 1998 Mar;54(1):59-69.

PMID:
9660072
38.

Comparisons of highly virulent H5N1 influenza A viruses isolated from humans and chickens from Hong Kong.

Suarez DL, Perdue ML, Cox N, Rowe T, Bender C, Huang J, Swayne DE.

J Virol. 1998 Aug;72(8):6678-88.

39.

Evolution of H5 subtype avian influenza A viruses in North America.

García M, Suarez DL, Crawford JM, Latimer JW, Slemons RD, Swayne DE, Perdue ML.

Virus Res. 1997 Oct;51(2):115-24.

PMID:
9498610
40.

Virulence-associated sequence duplication at the hemagglutinin cleavage site of avian influenza viruses.

Perdue ML, García M, Senne D, Fraire M.

Virus Res. 1997 Jun;49(2):173-86.

PMID:
9213392
41.

Pathogenicity and diagnosis of H5N2 Mexican avian influenza viruses in chickens.

Swayne DE, Perdue ML, Garcia M, Rivera-Cruz E, Brugh M.

Avian Dis. 1997 Apr-Jun;41(2):335-46.

PMID:
9201397
42.

Heterogeneity in the haemagglutinin gene and emergence of the highly pathogenic phenotype among recent H5N2 avian influenza viruses from Mexico.

García M, Crawford JM, Latimer JW, Rivera-Cruz E, Perdue ML.

J Gen Virol. 1996 Jul;77 ( Pt 7):1493-504.

PMID:
8757992
43.

Assessment of the ability of ratite-origin influenza viruses to infect and produce disease in rheas and chickens.

Swayne DE, Beck JR, Perdue ML, Brugh M, Slemons RD.

Avian Dis. 1996 Apr-Jun;40(2):438-47.

PMID:
8790896
44.

An Arg-Lys insertion at the hemagglutinin cleavage site of an H5N2 avian influenza isolate.

Perdue ML, Garcia M, Beck J, Brugh M, Swayne DE.

Virus Genes. 1996;12(1):77-84.

PMID:
8879123
45.
46.

Consistent occurrence of hemagglutinin variants among avian influenza virus isolates of the H7 subtype.

Perdue ML, Latimer J, Greene C, Holt P.

Virus Res. 1994 Oct;34(1):15-29.

PMID:
7831962
47.
49.
50.

Amantadine resistance among hemagglutinin subtype 5 strains of avian influenza virus.

Wainright PO, Perdue ML, Brugh M, Beard CW.

Avian Dis. 1991 Jan-Mar;35(1):31-9.

PMID:
1827579

Supplemental Content

Loading ...
Support Center